These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 981540)

  • 1. [Preliminary experiences in the treatment of metastatic mamma carcinoma by polychemotherapy-according to Cooper (author's transl)].
    Barndt J
    Radiobiol Radiother (Berl); 1976; 17(3):355-63. PubMed ID: 981540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].
    Estapé J; Millá A; Prats M; Herranz M; Visa J
    Med Clin (Barc); 1979 Aug; 73(4):136-9. PubMed ID: 481010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M; Fernholz HJ; Frik W
    Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

  • 8. [The period of time between operation and irradiation of a mamma carcinoma and its cytostatic treatment (author's transl)].
    Dietz R; Tkocz HJ
    Strahlentherapie; 1979 Mar; 155(3):160-2. PubMed ID: 432888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W; Nagel G; Senn HJ
    Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the metastasizing carcinoma of the breast (author's transl)].
    Brunner KW; Martz G
    Ther Umsch; 1973 Sep; 30(9):646-50. PubMed ID: 4584457
    [No Abstract]   [Full Text] [Related]  

  • 14. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 15. Disseminated breast carcinoma. Treatment with combination chemotherapy.
    Spigel SC; Coltman CA; Costanzi JJ
    Arch Intern Med; 1973 Oct; 132(4):575-7. PubMed ID: 4742410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM; Bruntsch U; Schmidt CG
    Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of breast cancer.
    Mitchell MS
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.